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Conclusion: Genomic-wide analysis of drug resistance sus-
pected isolates is recommended in order to ﬁnd the possible drug
resistance early in the therapy period. Whole genome analysis of
drug resistance by NGS technique enables rapid identiﬁcation of
drug resistant tuberculosis and initiation of appropriate therapy.
http://dx.doi.org/10.1016/j.ijid.2016.02.369
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Background: Urinary antigen testing has been proven to be
the most powerful diagnostic method to detect Legionella antigen
which is recognized as the causative agent of Legionnaires disease.
L. pneumophila peptidoglycan-associated lipoprotein (PAL) protein
is a extremely conserved antigen among Legionella species.
Methods & Materials: Rabbit and rat anti-PAL immunoglob-
ulin G (IgG) antibodies were produced by immunization with
the puriﬁed, recombinant PAL (r-PAL) protein of L. pneumophila
serogroup 1 and used as capture and detection antibodies in the
PAL antigen-based enzyme-linked immunosorbent assay (ELISA)
to detect urinary PAL antigen. Urine samples obtained from rats
experimentally infected with L. pneumophila serogroup 1. The per-
formance of the PAL antigen-based ELISA was measured on 40
infected urine samples and 40 controls obtained from the unin-
fected rats.
Results: After choosing the cutoff value of 0.192, the sensitiv-
ity and speciﬁcity of the PAL antigen-based ELISA were 87.5% and
97.5%, respectively. The results obtained by PAL antigen base ELISA
were compared with those obtained by Biotest. All of the con-
trol human urine samples were negative by the PAL antigen-based
ELISA.
Conclusion: The present report represents an extension of our
efforts to design an ELISA kit for detection of the PAL urinary anti-
gen in Legionnaires disease (LD). The PAL antigen-based ELISA
assay was relatively simple to perform, precise, highly sensitive
and speciﬁc, and reproducible. The PAL antigen-based ELISA results
yielding values which are almost equivalent to those found with
the same samples run by the Biotest EIA. Taken together, the data
indicated that the PAL antigen-based ELISA described here is the
ﬁrst indirect sandwich ELISA for urinary antigen detection which it
could easily be applied for diagnosis of LD.
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Studies on incidence of malaria and
comparative efﬁcacy of diagnostic test methods
for plasmodium falciparum and p. vivax
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Background: Diagnostic methods are becoming a crucial com-
ponent of malaria control and prevention. Improved ability to
diagnose malaria may prevent many unnecessary antimalarial
treatments and should also allow prompt attention to other causes
of fever when malaria is ruled out.
Methods&Materials: This studycompared thediagnostic accu-
racy of Bioline SD (HRP-2) and ACON (HRP-2/Aldolase) based RDTs
with microscopy. Blood samples were collected from 200 asymp-
tomatic and 60 symptomatic subjects in Ado-Odo/Ota LGA, Ogun
state. The blood samples collected were ﬁrst analyzed using the
Rapid Diagnostic Tests and then stained with Giemsa stain and
viewed under the microscope.
Results: Out of the samples collected from asymptomatic sub-
jects, 44% were males while 66% were females. Among the samples
from symptomatic patients, 58.3% were females. The overall inci-
dence of falciparum malaria among the study population by
microscopy was 32.3%. Among the asymptomatic patients only,
the percentage incidence from microscopy was 26.5% with 11%
males and 15.5% females; by Bioline SD (HRP-2) kits, the incidence
was 17%with 6.5% males and 10.5% females; while by ACON (HRP-
2/Aldolase), percentage incidencewas18% forP. falciparum, 6%were
males and 12% were females. Among the symptomatic subjects,
incidence rate of P. falciparum malaria was 42% by ACON kits, 38.3%
by Bioline SD and 51.7% microscopic method with 58.1% males and
41.9% females.Two samples were positive for P. vivax when diag-
nosedwith ACON (HRP 2/ Pan) butwas not detected bymicroscopy
Conclusion: There is the need to improve on the efﬁcacy of
available Rapid Diagnostic Test methods and their sensitivity in
indicating the presence of P. falciparum and P. vivax antigens in the
blood
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